Stmnt re Share Price Movement

RNS Number : 2618Y

Omega Diagnostics Group PLC

07 September 2020

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Statement regarding Share Price Movement

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the statement made by BBI Solutions Limited earlier today regarding an order from the UK Government and successful independent evaluations in relation to the AbC-19™ test developed by the UK-RTC. This was released by BBI in error and contained incorrect information. The statement has been withdrawn by BBI and should be disregarded. Any future updates on potential UK Government orders or the outcome of independent evaluations will be disclosed to shareholders once these are concluded.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Edward Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

SPMEADNXEDAEEFA